Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Zepbound: The Newest FDA-Approved Weight Loss Shot Zepbound, also containing tirzepatide as its active ingredient, represents the newest addition to FDA-approved GLP1 weight loss shots specifically indicated for chronic weight management
What clinical trials show Large-scale clinical trials have measured average weight loss across thousands of participants: Wegovy (semaglutide 2.4 mg) : Participants in the STEP 1 trial lost an average of 14.9% of their body weight over 68 weeks
These habits can also support long-term weight loss goals while on treatment
If your diet is rich in these nutrients, you may see results faster
The safety and effectiveness of combining semaglutide with other ingredients has not been established
US$ 29.71
US$ 21.22
US$ 25.41
US$ 23.73
US$ 22.13
US$ 27.81
US$ 27.85
